BeyondSpring (BYSI) Fundamentals 2026 — Revenue Analysis | SniperIQ

.20 on the NASDAQ. This SniperIQ fundamentals page covers BeyondSpring's valuation, profitability (net margin 0.0%), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is BeyondSpring's market cap?

BeyondSpring (BYSI) has a market capitalization of approximately $49M, trading at

.20 on the NASDAQ. Market cap moves with the live share price.

How profitable is BeyondSpring?

BeyondSpring runs a net profit margin of 0.0%, a gross margin of 0.0%, and an operating margin of 0.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

Does BeyondSpring pay a dividend?

BeyondSpring does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is BeyondSpring financially healthy?

BeyondSpring carries a debt-to-equity ratio of -0.01x and a current ratio of 1.09x, with a market beta of 0.42. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is BeyondSpring a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For BeyondSpring (BYSI) the key facts are: market cap $49M, 52-week range 1.16-2.44. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.